HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
28 hedge funds and large institutions have $4.24M invested in Hepion Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
8
Closed
6
Calls
$145K
Puts
$11K
Net Calls
+$134K
Net Calls Change
-$488K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$61.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.9K |
| 3 |
VF
Virtu Financial
New York
|
+$13K |
| 4 |
Jane Street
New York
|
+$9.78K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.83K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$98.6K |
| 2 |
Two Sigma Advisers
New York
|
-$20.3K |
| 3 |
State Street
Boston,
Massachusetts
|
-$20K |
| 4 |
Goldman Sachs
New York
|
-$19K |
| 5 |
JWM
JGP Wealth Management
Bend,
Oregon
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFEC
26
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $1K | -$4K | -4 | -80% |
|
|
IA
27
IFP Advisors
Tampa,
Florida
| $1K | -$1K | – | – |
|
|
CS
28
Credit Suisse
Zurich,
Switzerland
| $1K | +$1K | +2 | New |
|
|
29
Goldman Sachs
New York
| – | -$19K | -15 | Closed |
|
|
JWM
30
JGP Wealth Management
Bend,
Oregon
| – | -$17K | -15 | Closed |
|
31
Citadel Advisors
Miami,
Florida
| – | -$16K | -12 | Closed |
|
|
PFS
32
Prospera Financial Services
Dallas,
Texas
| – | -$10K | -8 | Closed |
|
33
Citigroup
New York
| – | -$5K | -4 | Closed |
|
34
UBS Group
Zurich,
Switzerland
| – | -$2K | -2 | Closed |
|